Cabot Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cabot Wealth Management's AMGN Position: Q1 2023 in Review
Cabot Wealth Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 45,547 shares — an estimated $12M sold.
Cabot Wealth Management first reported a position in AMGN in Q4 2018 and held it in 17 quarters. The position peaked at $13.8M in Q2 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.
- Cabot Wealth Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
- Cabot Wealth Management sold 45,547 Amgen shares in Q1 2023, an estimated $12M.
- Cabot Wealth Management first reported a position in Amgen in Q4 2018 and held it in 17 quarters.
- Cabot Wealth Management's Amgen position peaked at $13.8M in Q2 2022.
- 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.
Based on Cabot Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.